Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Atlas Arteria (ALX.AX)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2020-12-28NaN6.10Neutral
2021-02-255.495.75Neutral
2021-08-266.306.85Neutral
2022-03-046.436.58Neutral
2022-04-206.786.53Neutral
2022-06-088.25-No Rating
2022-09-017.967.15Neutral
2022-09-137.81-No Rating
2022-12-196.876.75Neutral
2023-01-256.776.65Neutral
2023-02-276.776.55Neutral
2023-07-246.266.65Neutral
2023-09-285.616.05Neutral
2023-10-215.375.70Neutral

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.